H2MF

DIETARY_SUPPLEMENT2 trials

Sponsors

University of Manitoba, Thomas Abrahamsson, MD, PhD

Conditions

Microbial ColonizationMortalityNecrotizing EnterocolitisOxidative StressPremature BirthSepsisVery Low Birth Weight Baby

Phase 2

Human Milk Fortification in Extremely Preterm Infants

Active, not recruitingNCT03797157

Thomas Abrahamsson, MD, PhDMortality, Necrotizing Enterocolitis, Sepsis

Start: 2019-02-01End: 2029-01-31Updated: 2024-07-23

Unknown Phase

Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature Infants

CompletedNCT03214822

University of ManitobaMicrobial Colonization, Oxidative Stress, Premature Birth +1

Start: 2017-08-01End: 2019-07-30Updated: 2019-09-30

Related Papers

Effect of human milk-based fortification in extremely preterm infants fed exclusively with breast milk: a randomised controlled trial.

2024-01-0228 citations

Source of human milk (mother or donor) is more important than fortifier type (human or bovine) in shaping the preterm infant microbiome

Cell Reports Medicine2022-08-2648 citations

Nordic study on human milk fortification in extremely preterm infants: a randomised controlled trial—the N-forte trial

BMJ Open2021-11-0111 citations